Cargando…
A small molecule p53 activator attenuates Fanconi anemia leukemic stem cell proliferation
Although p53 mutations are common in solid tumors, such mutations are found at a lower frequency in hematologic malignancies. In the genetic disorder Fanconi anemia (FA), p53 has been proposed as an important pathophysiological factor for two important hematologic hallmarks of the disease: bone marr...
Autores principales: | Du, Wei, Li, Xiaoli, Wilson, Andrew F., Pang, Qishen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5963145/ https://www.ncbi.nlm.nih.gov/pubmed/29784053 http://dx.doi.org/10.1186/s13287-018-0882-5 |
Ejemplares similares
-
Cell-Cycle-Specific Function of p53 in Fanconi Anemia Hematopoietic Stem and Progenitor Cell Proliferation
por: Li, Xiaoli, et al.
Publicado: (2018) -
Inactivation of the NHEJ Activity of DNA-PKcs Prevents Fanconi Anemia Pre-Leukemic HSC Expansion
por: Chatla, Srinivas, et al.
Publicado: (2019) -
The Fanconi anemia pathway controls oncogenic response in hematopoietic stem and progenitor cells by regulating PRMT5-mediated p53 arginine methylation
por: Du, Wei, et al.
Publicado: (2016) -
The non-homologous end-joining activity is required for Fanconi anemia fetal HSC maintenance
por: Nie, Yan, et al.
Publicado: (2019) -
Hyper-active non-homologous end joining selects for synthetic lethality resistant and pathological Fanconi anemia hematopoietic stem and progenitor cells
por: Du, Wei, et al.
Publicado: (2016)